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ABSTRACT 
Increased oxidative stress and hormonal imbalance have been hypothesized to underlie infer-
tility in obese animals. However, recent evidence suggests that Ghrelin and Stem Cell Factor 
(SCF) play an important role in fertility, in lean individuals. Therefore, this study aimed at 
investigating whether changes in the levels of Ghrelin and SCF in rat testes underlie semen 
abnormal parameters observed in obese rats, and secondly, whether endurance exercise or 
Orlistat can protect against changes in Ghrelin, SCF, and/or semen parameters in diet induced 
obese rats. Obesity was modelled in male Wistar rats using High Fat Diet (HFD) 12-week 
protocol. Eight week-old rats (n=40) were divided into four groups, namely, Group I: fed with 
a standard diet (12 % of calories as fat); Group II: fed HFD (40 % of calories as fat); Group 
III: fed the HFD with a concomitant dose of Orlistat (200 mg/kg); and Group IV: fed the HFD 
and underwent 30 min daily swimming exercise. The model was validated by measuring the 
levels of testosterone, FSH, LH, estradiol, leptin, triglycerides, total, HDL, and LDL choles-
terol, and final change in body weight. Levels were consistent with published obesity models 
(see Results). As predicted, the HFD group had a 76.8 % decrease in sperm count, 44.72 % 
decrease in sperm motility, as well as 47.09 % increase in abnormal sperm morphology. Un-
like the control group, in the HFD group (i.e. obese rats) Ghrelin mRNA and protein were el-
evated, while SCF mRNA and protein were diminished in the testes. Furthermore, in the HFD 
group, SOD and GPx activities were significantly reduced, 48.5±5.8 % (P=0.0012) and 
45.6±4.6 % (P=0.0019), respectively, while TBARS levels were significantly increased 
(112.7±8.9 %, P≤0.0001). Finally, endurance exercise training and Orlistat administration in-
EXCLI Journal 2014;13:551-572 – ISSN 1611-2156 
Received: January 07, 2014, accepted: May 08, 2014, published: May 26, 2014 
 
 
 
552 
dividually and differentially protected semen parameters in obese rats. The mechanism in-
cludes, but is not limited to, normalizing the levels of Ghrelin, SCF, SOD, GPx and TBARS. 
In rat testes, diet induced obesity down regulates SCF expression, upregulates Ghrelin expres-
sion, and deteriorate oxidative stress levels, which are collectively detrimental to semen pa-
rameters. Exercise, and to a lesser extent Orlistat administration, protected effectively against 
this detrimental effect.  
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INTRODUCTION 
It is estimated that more than 1 billion 
adults around the world are overweight and 
at least one third of this population has a 
BMI that exceeds 30 kg/m2, and as such are 
classified as obese (Ogden et al., 2006; 
Pasquali, 2006; Ferris and Crowther, 2006). 
While genetic predisposition, age, and envi-
ronmental factors may contribute to a per-
son’s tendency to gain weight, it is accepted 
that the two primary causes of obesity are 
increased intake of energy-rich foods and 
reduced physical activity (Ogden et al., 
2006). While obesity has been associated 
with a host of cardiovascular diseases, meta-
bolic syndrome, and a wide variety of endo-
crine abnormalities, recent data suggested a 
potential link between obesity and male in-
fertility (Pasquali, 2006; Ferris and 
Crowther, 2011). This association has merit-
ed investigation over the past decade because 
of the concurrent trends of rising obesity, 
increasing male factor infertility, and declin-
ing semen quality (Hammoud et al., 2008).  
There are now several but little popula-
tion-based studies showing that overweight 
and obese men have up to 50 % higher rate 
of sub-fertility when compared to men with 
normal weight (WHO, 2005; Sunderam et 
al., 2009). These studies have shown that 
overweight and obese men present hormonal 
changes such as lower plasma levels of sex 
hormone-binding globulin, total and free tes-
tosterone, luteinizing hormone (LH) and fol-
licle-stimulating hormone (Haffner et al., 
1993; Magnusdottir et al., 2005). Neverthe-
less, lower sperm count (Jensen et al., 2004; 
Sallmen et al., 2006), reduced semen quality 
(Magnusdottir et al., 2005), decreased nor-
mal-motile sperms and increased DNA 
fragmentation index (Magnusdottir et al., 
2005) were described in men who showed 
increased body mass index (BMI) and diet-
induced obesity (Bakos et al., 2011; Fernan-
dez et al., 2011). Decreased ejaculate vol-
umes and lower fertilization rate were also 
reported in rats (Bakos et al., 2011; Gha-
nayem et al., 2010), as well as increased 
number of couples seeking reproductive 
technologies (Wang et al., 2008; Sunderam 
et al., 2009). Intervention wise, Sallmen et 
al. (2006) reported that programs including 
diet, exercise or medication to prevent obesi-
ty may improve men’s reproductive health 
and save medical costs for infertility treat-
ment.  
Ghrelin is an acylated polypeptide hor-
mone that is secreted predominantly by P/D1 
cells lining the fundus of human stomach 
and epsilon cells of the pancreas (Inui et al., 
2004). It plays a major role in the control of 
growth hormone, energy balance, food in-
take as well as body weight (Broglio et al., 
2002). However, recent evidence indicates 
that Ghrelin carries out a wide array of pe-
ripheral effects including the pancreas, lym-
phocytes, kidney, lung, heart, pituitary, 
brain, ovaries, placenta and testis (Broglio et 
al., 2002; Gualillo et al., 2003; Van der Lely 
et al., 2004). In the testis, Ghrelin immuno-
reactivity has been localized mainly to 
Leydig cells, which release testosterone in 
response to LH release from the anterior pi-
tuitary. Ghrelin immunoreactivity is also 
found to a lesser extent in Sertoli cell precur-
sor located in the seminiferous tubules. 
Those are known to express receptors for 
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Follicular Stimulating Hormone (Gaytan et 
al., 2004), suggesting a role in the regulation 
of spermatogenesis. Indeed studies have 
shown that Ghrelin delays pubertal onset in 
male rats inhibits stimulated testicular testos-
terone secretion and control of proliferation 
of Leydig cells (Tena-Sempere et al., 2002; 
Barreiro et al., 2004). In the pituitary, 
Ghrelin suppressed LH pulse frequency in 
rats, sheep, monkeys (Fernandez-Fernandez 
et al., 2004; Harrison et al., 2008; Vulliemoz 
et al., 2008) and humans (Lanfranco et al., 
2008). Exogenous Ghrelin has been shown 
to inhibit LH secretion in rats, both in vivo 
and in vitro (Furuta et al., 2001; Fernandez-
Fernandez et al., 2004) and suppresses FSH 
secretion in males and females (Vulliemoz et 
al., 2008; Lanfranco et al., 2008). Further, 
intratesticular injection of Ghrelin (15 μg for 
2 days) in adult rats, inhibited SCF mRNA 
expression (Barreiro et al., 2004). Ghrelin is 
a key signal for germ cell production, a puta-
tive regulator of Leydig cell development 
and survival factor for the different cell types 
in the seminiferous epithelium (e.g. sperma-
togonia) (Rossi et al., 2000; Lanfranco et al., 
2008). Such inhibitory action of Ghrelin on 
SCF has also been detected in vitro using 
cultures of staged seminiferous tubules sug-
gesting that immature Leydig cells induce 
differentiation in an SCF-dependent mecha-
nism (Barreiro et al., 2004).  
Incidentally, little attention was directed 
to the role of testicular expression of SCF 
and/or Ghrelin in obese subjects or animals 
with sexual dysfunction. The hypothesis be-
ing tested here is that obesity induces 
Ghrelin expression, which in turn downregu-
lates SCF and results in semen abnormali-
ties; an effect that is reversible non-
pharmacologically using endurance exercise 
or pharmacologically using lipase inhibitor 
Orlistat. If this hypothesis is correct, then 
this will reveal new and effective therapeutic 
strategies for obesity-induced reproductive 
impairment, including weight reduction 
(Strain et al., 1988; Bastounis et al., 1998; 
Kaukua et al., 2003; Van Dorsten and Lind-
ley, 2008; Hammoud et al., 2009; Villareal et 
al., 2011), and/or SCF gene expression-
modifiers (i.e. pharmacological and non-
pharmacological).  
Orlistat (Xenical), is a pharmacological 
agent that promotes weight loss in obese 
subjects via inhibiting gastric and pancreatic 
lipase. At three daily doses of 120 mg, it re-
duces fat absorption by 30 % and has been 
proven useful n facilitating both weight loss 
and weight maintenance (Tiikkainen et al., 
2004). In clinical use, lipase inhibitors may 
be effective in reducing dietary fat intake by 
reducing both the consumption and absorp-
tion of fat (Ellrichmann et al., 2008). It has 
been reported that Orlistat is highly efficient 
when given in conjugation with a high fat 
diet. Indeed, higher doses of Orlistat provid-
ed to rats led to 54 % reduction in fat absorp-
tion, whereas, in humans, the expected re-
duction was 30 % (Filippatos et al., 2008).  
An alternative intervention to weight 
control and reduction is endurance exercise. 
There is a considerable body of literature 
supporting the use of endurance exercise as a 
protocol for weight loss and health im-
provement. Body weight reduction in hu-
mans or animals promoted by high-intensity 
exercise training originated from the obser-
vation that following high-intensity glyco-
gen-depleting exercise, lipid usage during 
recovery periods was greatly elevated (Yo-
shioka et al., 2001). When exercise results in 
glycogen depletion, muscle glycogen reple-
tion is of high metabolic priority, resulting in 
the preferential use of intramuscular triacyl-
glycerol and circulating lipids by the recov-
ering skeletal muscle (Kiens and Richter, 
1998).  
In this study, the effects of HFD-induced 
obesity on the levels of testicular Ghrelin, 
SCF, TBARS, activities of SOD and GPx, 
and on the standard semen parameters is be-
ing tested. The second part of the study fo-
cused on assessing the effect of Orlistat 
alone, weight loss pharmacotherapy, and ex-
ercise alone, as a non-pharmacotherapy, on 
the above named markers when co-
administered with HFD protocol. 
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MATERIALS AND METHODS 
Materials  
Orlistat was obtained from Sigma Phar-
maceutical Industries (KSA) as capsules; 
each containing 120 mg Orlistat. ELISA kits 
for detecting rat serum leptin and Ghrelin 
were purchased from Abcam Biochemicals 
(USA; Cat. No. ab100773 and ab120231, 
respectively). ELISA kits for detecting rat 
serum total testosterone, estradiol and FSH 
were purchased from Cayman Chemical 
Company (USA; Cat. No. 582701, 582251, 
500710, respectively). ELISA kit for detect-
ing rat serum LH was obtained from Kamiya 
Biomedical Company (USA; Cat. No. KT-
21064). Assay kit for determination of 
Malondialdehyde (MDA) in tissues was ob-
tained supplied from NWLSS (USA; Cat. 
No. NWK-MDA01). Determination of tissue 
levels of Superoxide Dismutase (SOD) and 
glutathione peroxidase (GPx) activities was 
performed using assay kits from Caymen 
Chemicals (USA; Cat. No. 706002 and 
703102, respectively). Serum lipids includ-
ing total triglycerides (TG), total cholesterol 
(TC), High Density Lipoproteins (HDL) and 
Low Density Lipoprotein cholesterol (LDL) 
were determined using colorimetric Kits 
from Human Company (Germany).  
 
Animals  
Eight-week old male Wistar rats (n=40) 
weighing 280-300 g were obtained from rats 
breeding colony at the Animal House of the 
College of Medicine at King Khalid Univer-
sity, Abha, Saudi Arabia. Rats were housed 
in a 4 rat-cages. Rats in all treatment groups 
were preconditioned for one week prior to 
implementing treatment protocol. During 
this time, rats received standard chow diet 
and water ad-libitum and were kept at room 
temperature of 22 ± 2 ° 
C, relative humidity of 55 ± 10 % and a 
light/dark cycle of 12 hours. All experi-
mental procedures were conducted in strict 
compliance with the Animal Welfare Act, 
Public Health Services Policy, National In-
stitute of Health Guide for the Care and Use 
of Laboratory Animals as well as the proto-
col approved by King Khalid University An-
imal Care Committee.  
 
Experimental design  
Rats were permitted to adapt for one 
week prior to implementing the protocol that 
follows. Four rat groups, 10 each, were 
formed: Group 1 (Control; non-obese): in-
cluded rats which were fed a standard diet 
(12 % of calories as fat; Table 1) for 12 con-
secutive weeks; Group 2 (HFD): included 
rats which were fed HFD (40 % of calories 
as fat; Table 1) for 12 consecutive weeks ac-
cording to the protocol of Tuzcu et al. 
(2011); Group 3 (HFD + Orlistat): included 
rats which were fed the HFD and received a 
concomitant therapeutic dose of Orlistat 
(200 mg/kg) for 12 weeks according to the 
method of Nishioka et al. (2003); and Group 
4 (HFD + exercise): included rats that were 
fed the HFD and underwent a simultaneous 
daily swimming exercise (30 min/day) for 12 
consecutive weeks. Swimming exercise was 
done in a glass tank (dimensions: 100 cm 
(L)*40 cm (W)*60 cm (H)) and water depth 
in the tank was set at 30 cm. The swimming 
training was always performed at water tem-
perature of 32 °C between 10:00 to 12:00 h 
a.m. This method of endurance exercise 
training was selected because it showed ad-
vantages over other training exercise proto-
cols including treadmill protocol; namely 
swimming is a natural ability in rats as well 
as the strength of this exercise to generate 
physiologically significant exertion in rats 
needed for this experimental design (Lee et 
al., 2009; Da Luz et al., 2011). Rats were 
adapted to the water environment before the 
beginning of the experiment by placing them 
in shallow water at 32 °C between 10:00 to 
12:00 a.m. The adaptation period was carried 
out during the week prior to swimming train-
ing onset. The purpose of the water adaption 
was to reduce stress without promoting phys-
ical training adaption.  
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Table 1: Ingredients and nutrient composition of 
rat high-fat diet 
Ingredients 
 
Standard 
Diet 
(g/kg) 
 
High-Fat 
Diet (HFD) 
(g/kg) 
 
Casein 200.0 200.0 
Starch 615.0 145.0 
Sucrose 000.0 150.0 
Corn oil 080.0 000.0 
Beef tallow 000.0 400.0 
Cellulose 050.0 050.0 
Vitamin-Mineral 
Premix 
050.0 050.0 
DL-Methionine 003.0 003.0 
Choline chloride 002.0 002.0 
 
 
Methods  
(A) Body weight gain and biochemical  
analysis  
Body weight for all rats in every group 
was recorded before study initiation (Day 0) 
and at the end of week 12 of the protocol. 
Then, rats were anesthetized with diethyl 
ether and 3 ml blood samples were collected, 
using 3 ml syringe directly from the heart 
using ventricular puncture method, into plain 
5 ml untreated glass tubes where they were 
allowed to clot for 15 min at RT. Samples 
were centrifuged at 4000 rpm for 10 min to 
separate the serum, which was used to de-
termine the levels of TG, TC, HDL, LDL, 
testosterone, estradiol, FSH, LH, leptin as 
well as Ghrelin, as per manufacturer’s in-
structions.  
 
(B) Adiposity index  
After blood collection, animals were sac-
rificed by decapitation, and adipose tissue 
was isolated and weighed from the epididy-
mal, visceral and retroperitoneal pad. Adi-
posity index was determined by the sum of 
epididymal, visceral and retroperitoneal fat 
weights divided by body weight × 100 %, 
then expressed as adiposity percentage (i.e. 
Adiposity Index; Amato et al., 2014). Fur-
ther, the right testis and epididymis were re-
moved and their weights recorded (i.e. abso-
lute weight). Epididymis relative weight to 
body weight was calculated, and the epidi-
dymis was used for fresh sperm count. The 
right testis from each rat in all 4 groups was 
then frozen at -80 °C for the determination of 
daily sperm production. At the same time, 
the left testis was frozen in liquid nitrogen 
and stored at -80 °C which was used later for 
the determination of Ghrelin and Ghrelin 
mRNA, Ghrelin and SCF protein levels, 
MDA levels, and the activities of SOD and 
GPx.  
 
(C) Semen analysis: sperm count and  
motility  
Right cauda epididymis from each rat in 
all four groups was weighed, diluted in 1:20 
physiological saline solution (0.9 % NaCl) in 
a Petri dish and minced with a scalpel blade 
in the mid-to-distal region of the epididymis. 
The suspension was kept at 37 °C for 5 min 
to allow the sperms to disperse in the medi-
um. Sperm suspension was gently mixed 20 
times and placed in a hemocytometer where 
the total number of sperms were counted un-
der a Nikon microscope (Nikon Eclips E600) 
at 400X final magnification. Sperms were 
counted in 5 small squares of the main large 
central square, where each square consists of 
16 smaller squares. Therefore, a correction 
factor of 50 was applied to calculate the total 
number of sperm per ml then converted to 
0.1 g tissue weight. Two samples were 
counted per epididymis, and one epididymis 
was collected from each of the 10 rats in 
each experimental group. Further sample 
analysis included counting motile and immo-
tile sperm in a total of 400 sperm-sample and 
the results were expressed as a percent.  
 
(D) Semen analysis: sperm morphology  
A drop of Eosin stain was added to pre-
viously prepared sperm suspension that was 
kept for 5 min at 37 °C. Then, a drop of 
sperm suspension was placed on a clean 
slide and was gently spread to make a thin 
film. The film was air dried and then ob-
served under a microscope for changes in 
sperm morphology according to the method 
of Feustan et al. (1989). The following 
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sperm abnormalities were counted in two 
separate fields, in each of the sperm samples 
described above: absence of head; absence of 
the tail; tail bending; tail curving; tail loop-
ing; tail coiling; mid-piece curving; and mid-
piece bending.  
 
(E) Semen analysis: estimation of daily 
sperm production  
Daily sperm production was estimated 
using the protocol described by Fernandes et 
al. (2007) where resistant sperms were 
counted following homogenization of the 
testis sample. Each of the frozen right decap-
sulated testes was homogenized in 5 ml 
0.9 % (w/v) NaCl and Triton X-100 (0.05 %, 
v/v) using a Waring blender. The preparation 
was diluted 10 folds and 4 samples were 
transferred to a Neubauer chamber and late 
spermatids were counted. The variation be-
tween duplicate testicular sperm counts was 
less than 10 %. Daily sperm production 
(DSP) values were obtained using a transit 
time factor of 6.1 days; the duration for 
which spermatids are typically present in the 
seminiferous epithelium.  
 
(F) Preparation of tissue homogenates for 
oxidative stress experiment 
Frozen parts of testes from all groups 
were washed with phosphate buffered saline 
(PBS), pH 7.4, containing 0.16 mg/ml of 
heparin to remove any erythrocytes and 
clots. Then, they were homogenized with an 
ultrasonic homogenizer in cold phosphate 
buffer, pH 7.0 with ethylenediaminetetra-
acetic acid (EDTA), for thiobarbituric acid 
reactive substances (TBARS) measurement, 
and with cold 20 mM N-(2-hydroxyethyl) 
piperazine-N'-2-ethanesulfonic acid 
(HEPES) buffer, pH 7.2, containing 1 mM 
ethylene glycol-bis (2-aminoethoxy)-tetra-
acetic acid (EGTA), 210 mM mannitol, and 
70 mM sucrose, for the measurement of 
SOD activity. Also, other parts of the kid-
neys and livers were homogenized in cold 
buffer that consists of 50 mM tris-HCl, pH 
7.5, 5 mM ED-TA, 1 nM DTT to measure 
GPx activity. All supernatants were kept in 
separate tubes and stored at -20 °C.  
 
(G) Measurement of thiobarbituric acid  
reactive substances (TBARS) levels  
Lipid peroxidation levels in testes’ ho-
mogenates were measured by the thiobarbi-
turic acid (TBA) reaction. This method was 
used to measure spectrophotometrically the 
colour produced by the reaction of TBA with 
MDA at 532 nm. To this end, TBARS levels 
were measured using MDA assay according 
to manufacture’s instruction. Briefly, tissue 
supernatant (50 μl) was added to test tubes 
containing 2 μl of butylated hydroxytoluene 
(BHT) in methanol. Next, 50 μl of acid rea-
gent (1 M phosphoric acid) was added fol-
lowed by 50 μl of TBA solution. Tubes were 
mixed vigorously and incubated for 60 min 
at 60 °C. The mixture was centrifuged at 
10,000 × g for 3 min, and the supernatant 
was placed into wells on a microplate in 
75 μl aliquots, and absorbance was measured 
with a plate reader at 532 nm. TBARS 
(MDA) levels were expressed as nmol/mg 
protein.  
 
(H) Measurement of superoxide dismutase 
(SOD) activity  
SOD activity in testes’ homogenates was 
measured using a commercial assay kit ac-
cording to the manufacturer’s instructions. 
The SOD assay consisted of a combination 
of the following reagents: 0.3 mM xanthine 
oxidase, 0.6 mM diethylenetriamine-penta 
acetic acid (DETAPAC), 150 μM nitroblue 
tetrazolium (NBT), 400 mM sodium car-
bonate (Na2CO3), and bovine serum albu-
min (1.0g/l). The principle of the method is 
based on the inhibition of NBT reduction by 
superoxide radicals produced by the xan-
thine/xanthine oxidase system. For the assay, 
standard SOD solution and 10 μl of tissue 
homogenate supernatant were added to wells 
containing 200 μl of NBT solution, which 
was previously diluted by adding 19.95 ml of 
50 mM Tris-HCl, pH 8.0, containing 0.1 mM 
DETAPAC solution and 0.1 mM hypoxan-
thine. Finally, 20 μl of xanthine oxidase was 
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added to the wells at an interval of 20s . Af-
ter incubation at 25 °C for 20 min, the reac-
tion was terminated by the addition of 1.0 ml 
of 0.8 mM cupric chloride. The formazan 
was measured spectrophotometrically by 
reading the absorbance at 560 nm with the 
help of a plate reader. One unit (U) of SOD 
is defined as the amount of protein that in-
hibits the rate of NBT reduction by 50 %. 
The calculated SOD activity was expressed 
as U/mg protein. 
 
(I) Measurement of glutathione peroxidase 
(GPx) activity  
Glutathione peroxidase activity in testes 
homogenates was measured using the GPx 
Assay Kit as per manufacture’s instructions. 
The principal of the reaction is that GPx cat-
alyzes the reduction of hydroperoxides, in-
cluding hydrogen peroxide, by reduced glu-
tathione, and functions to protect the cell 
from oxidative damage. With the exception 
of phospholipid hydroperoxide GPX, a mon-
omer, all of the GPx enzymes are tetramers 
of four identical subunits. Each subunit con-
tains a selenocysteine in the active site, 
which participates directly in the two-
electron reduction of the peroxide substrate. 
The enzyme uses glutathione as the ultimate 
electron donor to regenerate the reduced 
form of the selenocysteine. The Cayman 
Chemical Glutathione Peroxidase Assay Kit 
measures GPx activity indirectly by a cou-
pled reaction with glutathione reductase 
(GR). Oxidized glutathione (GSSG) is pro-
duced upon reduction of hydroperoxide by 
GPx and is recycled to its reduced state by 
GR and NADPH. The oxidation of NADPH 
to NADP+ is accompanied by a decrease in 
absorbance at 340 nm. Under conditions in 
which the GPx activity is rate limiting, the 
rate of reduction in the A340 is directly pro-
portional to the GPx activity in the sample. 
GPx activity was presented as nmol/g pro-
tein. One unit is defined as the amount of 
enzyme that causes the oxidation of 0.1 nmol 
of NADPH to NADP+/min at 25 °C. 
(J) RT-PCR of SCF (soluble and mitochon-
drial) and Ghrelin mRNA in testicular tissue 
Testicular expression of SCF and Ghrelin 
mRNA was assessed using RT-PCR. The 
procedure was optimized for semiquantita-
tive detection using the primer pairs and 
conditions described in Table 2. Published 
sequence of PCR primers used for the detec-
tion of SCF and Ghrelin (Goddard et al., 
2001; Barreiro et al., 2002) was used. Total 
RNA was extracted from testicle tissue (30 
mg) using the RNeasy Mini Kit (Qiagen Pty. 
Ltd., Victoria, Australia) according to manu-
facturer’s instructions. Single strand cDNA 
synthesis was performed as follows: 30 µl of 
reverse transcription mixture containing 
1.0 µg of DNase I pretreated total RNA, 
0.75 µg of oligo d(T) primer, 6.0 µl of 5x RT 
buffer, 10 mM dithiothreitol, 0.5 mM deox-
ynucleotides, 50 U of RNase inhibitor, and 
240 U of Reverse Transcriptase (Invitrogen). 
The RT reaction was carried out at 40 °C for 
70 min followed by heat inactivation at 
95 °C for 3 min. The tested genes, SCF and 
Ghrelin and that of the internal control (β-
actin) were amplified by PCR using 2 µl RT 
products from each sample in a 20 µl reac-
tion containing Taq polymerase (0.01 U/ml), 
dNTPs (100 mM), MgCl2 (1.5 mM), and 
buffer (50 mM Tris-HCl). PCR reactions 
consisted of a denaturing cycle at 97 °C for 5 
min, followed by a variable number of cycles 
of amplification, defined by denaturation at 
96 °C for 30 sec, annealing for 30 sec, and 
extension at 72 °C for 1 min. A final exten-
sion cycle of 72 °C for 15 min was included. 
Annealing temperature was adjusted for each 
target: 57 °C for SCF and 63 °C for Ghrelin. 
10 µl of PCR product was electrophoresed 
using 2 % agarose gel containing 100 ng/ml 
ethidium bromide, then photographed with a 
Polaroid camera under ultraviolet illumina-
tion.  
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Table 2: Primers and conditions used in PCR reactions 
Target Primer Position Primer sequence (5
' to 3') AT (oC) Size (bp) 
SCFb Sc   : 661 – 682 
aSd: 881 – 911 
TGG TGG CAT CTG ACA CTA GTG A 
CTT CCA GTA TAA GGC TCC AAA AGC 
57 167 (SCFm) 
250 (SCFs) 
Ghrelin S    :205 – 224 
aS :451 – 430 
GAG GAC AGA GGA CAA GC 
TGC AGA GGA GGC AGA AGC T 
63 247 
AT: Annealing temperature 
b Chosen primers amplify both membrane (m) and soluble (s) forms of SCF 
c Sense 
d Antisense 
 
 
(K) Expressions of SCF and Ghrelin by 
Western blot analysis  
Frozen testes tissues from all groups of 
rats were homogenized in lysis buffer con-
taining 50 mM TRIS, 150 mM NaCl, 1 % 
NP-40, 0.5 % sodium deoxycholate, 1 % so-
dium dodecyl sulfate, 1.0 mM PMSF, sodi-
um orthovanadate, sodium fluoride, eth-
ylenediaminetetraacetic acid, and leupeptin 
at 4 °C for 30 min. Homogenates were cen-
trifuged at 12 000× g for 5 min at 4 °C, and 
the supernatants were collected and used as 
total protein. Approximately 100 µg of tissue 
protein extract was loaded onto each well, 
separated electrophoretically through a 
13.5 % SDS-polyacrylamide gel and trans-
ferred onto Sequi-Blot ™ PVDF membrane 
(BioRad, USA) by electroblotting. Skim fast 
milk powder (5 % w/v) in TBS/Tween-20 
buffer (137 mmol NaCl, 20 mmol Tris-HCl, 
pH7.4, 0.1 % Tween-20) was used to block 
filters for at least 1 hr at RT. 1:500 dilution 
of specific primary goat polyclonal antibody 
against Ghrelin (c-18) was used, and 1:200 
dilution for primary polyclonal antibody 
against SCF (H-189) (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) and 1:1000 
dilution for primary rabbit polyclonal anti-
bodies against ß-actin (Sigma Aldrich, Ger-
many) were used. The secondary antibody 
that was used was anti-goat or anti-rabbit 
IgG horseradish peroxidase-conjugated anti-
body (1:2000, Santa Cruz, USA). The sepa-
rate incubation of primary antibodies was 
followed by 3 washes with TBS-Tween-20 
buffer for 10 min. Incubation of the second-
ary antibody was followed by 4 washes for 
10 min. Chemiluminescent based detection 
was performed using BM chemilumines-
cence blotting substrate (Boehringer, Mann-
heim, Germany). Thereafter, the developed 
membrane was exposed to X-ray film (Ko-
dak, Wiesbaden, Germany). Comparisons 
between different treatment groups were 
made by determining the ratio of Ghrelin or 
SCF to ß-actin from same tissue sample us-
ing densitometry.  
 
(L) Statistical analysis  
Statistical analysis was performed by 
one-way ANOVA. The presence of signifi-
cant difference between treatment groups 
was accomplished using MANOVA. Post 
hoc comparison (Tukey’s t-test) was also 
used. Data were expressed as means ± stand-
ard deviation (SD) and statistical signifi-
cance was set at P ≤ 0.05. 
 
RESULTS 
Changes in final body weight, testis weight, 
fat deposits and adiposity index 
Results presented here show that a repro-
ducible and reliable rat model for High Fat 
Diet (HFD) induced obesity was successfully 
established in our lab. Supporting data in-
cludes significant body size increase (Figure 
1), weight increase (Figure 1), sperm analy-
sis Figure 1), adipose tissue deposition (Fig-
ure 2) and lipid profile (Figure 3). At the end 
of week 12, HFD obese group rats showed a 
significant increase (P =0.0148) in their final 
body weight; a gain of 65.2±3.1 % (Figure 
1A, A). There was also a significant increase 
in fat deposits including epididymal 
(80.1±6.7 %, P≤0.0001), visceral (35.6± 
4.5 %, P=0.0082) and retroperitoneal (59.8± 
3.89 %, P=0.0045), as well as the adiposity 
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index which was increased by 45.4±3.9 % 
(P=0.0053) (Figure 2A, Figure 2B). Addi-
tionally, the absolute weight of the testes and 
the epididymis was decreased by 72.3±5.3 % 
(P=0.0023) and 22.5±2.1 % (P=0.0232), re-
spectively. The relative weight of the testes 
and the epididymis was also decreased by 
99.6±6.7 % (P≤0.0001) and 33.3±1.7 % 
(P=0.0121), respectively (Figure 1A, B, C).  
 
 
Figure 1A: Upper panel shows pictures to demonstrate varification of our model group. (I): represents 
control rat at the end of week 12 while (II) shows obese rat administered HFD for the same period. 
Lower pannel (A-C) represents changes in body weight and testis and epididymis absolute and 
relative weight (in comparsion to final total body weight) in the control and the experimental groups of 
rats. Values are expressed as Mean ± SD for 10 rats in each group. Values were considered signifi-
cantly different at P < 0.05. *: Significantly different when compared to control group I. β: significantly 
different when compared to HFD obese group. λ: significantly different when compared to HFD + 
Orlistat group.  
 
 
 
 
Figure 1B: Photomicro-
graphs of sperm ob-
tained from dissected 
epididymis of rats in the 
Control, HFD, HFD + 
Orlistat and HFD + exer-
cise groups, showing 
increased total abnor-
malities including coiled 
tail (hort arrow), head-
less (arrow head), and 
tailless sperms (long 
arrow) in HFD induced 
obese and obese rats 
treated with Orlistat (B & 
C, respectively) and 
normal abnormalities in 
the control (A) and ex-
ercised obese group 
(D).  
A B
C D
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Figure 2: Weights of different fat deposits and percents of adiposity (adiposity index) in the control 
and the experimental groups of rats. Values are expressed as Mean ± SD for 10 rats in each group. 
Values were considered significantly different at P < 0.05, *: Significantly different when compared to 
control group I. β: significantly different when compared to HFD obese group. λ: significantly different 
when compared to HFD + Orlistat group 
 
 
 
 
Interestingly, the administration of Orlistat 
alone or implementation of endurance exer-
cise training alone did significantly reduce 
weight gain, adiposity index and fat deposits 
in the HFD fed rats. Also, there was a signif-
icant increase in the testes and the epididy-
mis absolute and relative weight (Figure 1A 
and Figure 2). Group 4 rats, which were ex-
posed to endurance exercise alongside HFD 
had significantly decreased epididymal and 
retroperitoneal fat deposits (10.1±1.0 % (P= 
0.0417); and 11.3±1.1 % (P=0.0431), respec-
tively (Figure 2A). Additionally, relative tes-
tes weight was significantly increased 
(15.3±1.4 %) (P=0.0312) in (Figure 1A and 
1C) as shown by ANOVA.  
 
Serum lipid profile and sex hormones  
Figure 3 revealed the changes detected in 
serum lipids including TG, TC, LDL and 
HDL in all of the 4 experimental groups. 
HFD obese rats showed a significant in-
crease (P < 0.05) in the serum levels of TG, 
TC and LDL with a significant reduction in 
HDL levels (P<0.0001). The levels of all of 
these serum lipids were significantly de-
creased in groups 3 and 4; HFD + Orlistat 
group or in HFD + exercise group when 
compared to HFD obese rats. Orlistat and 
exercise though reduced LDL levels com-
pared to HFD group, their levels did return 
to control non obese group levels.  
Figure 4 shows that there was a signifi-
cant reduction in the serum levels of circula-
tory testosterone (71.8±6.7 %, P=0.0026), 
FSH (41.8±4.1 %, P=0.0067), LH (33.3± 
3.6 %, P=0.0097) (Figure 4A and 4C), 
Ghrelin (66.7±5.98 %, P=0.0037) accompa-
nied by a significant increase in the levels of 
leptin (185.7±9.8 %, P≤0.0001) (Figure 4C) 
and estradiol (51.8±5.8 %, P=0.0034) (Fig-
ure 4B) when compared to control non obese 
rats. Exercise and Orlistat normalized the 
detrimental effect of HFD on semen charac-
teristics; keeping in mind the more pro-
nounced effect of exercise when compared to 
Orlistat on testosterone (25.0±2.1 %, 
p=0.0133) and FSH. 
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Figure 4: Serum levels of circulatory testosterone, Follicle-stimulating hormone (FSH), Luteinizing 
hormone (LH), estradiol, leptin and Ghrelin in the control and the experimental groups of rats. Values 
are expressed as Mean ± SD for 10 rats in each group. Values were considered significantly different 
at P < 0.05. *: Significantly different when compared to control group I. β: significantly different when 
compared to HFD obese group. λ: significantly different when compared to HFD + Orlistat group 
 
 
 
Sperm count, motility, DSP and  
morphology  
The results of epididymal sperm mor-
phology, count, daily sperm production and 
general appearance are shown in Table 3, 
Figure 1B and Figure 5, respectively. There 
was a significant decrease in the number 
(76.8±7.3 %, P < 0.0001) and motility (44.7± 
4.8 %, P=0.0081) of epididymal sperms (per 
0.1 g of epididymis), as well as in testicular 
homogenization resistant sperms (46.4± 
3.9 %, P=0.0039) Daily sperm production 
was also reduced (DSP/testis) (57.8±3.5 %, 
P=0.0012) in HFD obese rats as compared to 
Figure 3: Serum levels of total 
triglycerides (TG), total 
cholesterol (TC), high density 
lipoprotein cholesterol (HDL-C) 
and low density lipoprotein 
cholesterol (LDL-C) in the control 
and the experimental groups of 
rats. Values are expressed as 
Mean ± SD for 10 rats in each 
group. Values were considered 
significantly different at P < 0.05. 
*: Significantly different when 
compared to control group I. β: 
significantly different when com-
pared to HFD obese group. λ: 
significantly different when com-
pared to HFD + Orlistat group 
HFD + exercise 
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control rats (Figure 5A-D). Results obtained 
from the morphological assessment of sperm 
(Figure 1B) indicated that the percentage of 
abnormal sperms was significantly higher 
(39.94%) in the HFD group as compared to 
control non- obese group (14.79 %). The ma-
jority of abnormalities seen were increase in 
tailess (4.4 folds), headless (6.7 folds) and 
coiled tail sperm (5.22 folds). However, 
Group 3 (Orlistat + HFD) rats showed signi-
ficant improvement (P < 0.0001) in sperm 
count, motility and DSP as compared to rats 
in Group 2 (HFD obese) despite the fact that 
their absolute numbers remained significant-
ly lower than those of the control non obese 
rats (17.2±1.8 %, 13.3±1.1 %, 9.3±1.2 %, 
respectively). The total abnormalities in 
these groups of rats were slightly but signifi-
cantly decreased as compared to HFD group. 
The ANOVA analysis showed that Orlistat 
administration to HFD rats decreased only 
the percents of headless and coiled tail sperm 
as compared to HFD group but in spite of 
this decrease, headless sperm and coiled tail 
sperm remained significantly higher (4.6 and 
2.18 folds, respectively) as compared to con-
trol non obese group. Interestingly, Group 4 
(HFD + exercise) rats showed maximum re-
covery across sperm count, motility and all 
abnormalities examined and all these para-
meters were not significantly different when 
compared to their corresponding levels 
measured in the control non obese group of 
rats. However, sperm count remained slight-
ly and significantly lower than its count seen 
in the control non obese rats. 
 
Oxidative stress markers  
Table 4 shows the levels of lipid peroxi-
dation markers (TBARS) and activities of 
SOD and GPx; markers of protein oxidative 
damage in the testicular homogenates of 
normal and experimental animals. HFD ad-
ministration to rats for 12 weeks resulted in a 
significant increase in TBARS (112.7± 
8.9 %, P≤0.0001) as well as significant de-
creases in the activities of SOD (48.5±5.8 %, 
P=0.0012) and GPx (45.6±4.6 %, P=0.0019) 
in testis homogenates when compared to 
control group rats. However, no significant 
change was detected in the levels of TBARS, 
SOD or GPx activities in Group 3 (HFD + 
Orlistat) rats. On the other hand, endurance 
exercise training for 12 weeks restored the 
levels of TBARS and the activities of both 
SOD and GPx to the control levels thus nor-
malizing the effect of the HFD.  
 
 
 
Table 3: Characterization of sperm morphology in the epididymis of rats in control and experimental 
groups 
Mean 
Sperm  
Abnormality (%) 
Control HFD HFD + Orlistat HFD+ Exercise 
Tailless  2.84±0.38 12.54±2.124* 11.84±2.52* 2.13±0.29βλ 
Headless  1.65±0.35 11.32±2.14* 7.53±1.42*β 1.46±0.34β 
Bent tail  2.15±0.18 2.33±0.28 1.84±0.52 1.31±0.29*βλ 
Bent midpiece 1.28±0.028 1.30±0.026 1.38±0.035 1.35±0.029β 
Coiled tail  2.84±0.57 8.06±1.49* 6.2±0.56*β 2.53±0.86βλ 
Curved midpiece  2.53±0.29 2.93±0.44 2.31±0.086 2.59±0.399β 
Curved tail  1.5±0.0188 1.46±0.012 1.47±0.28 1.41±0.26 
Total abnormality  14.79 % 39.94 % 32.56 %*β 12.7 %βλ 
Values are presented as mean ± SD (n=10 rats) were considered significantly different at P < 0.05; *: Significantly different 
when compared to control group I. β: significantly different when compared to HFD obese group. λ: significantly different when 
compared to HFD + Orlistat group 
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Figure 5: Epididymal sperm count and motility and testicular homogenization resistant sperm and 
daily testis sperm production (DSP) levels in the control and the experimental groups of rats. Values 
are expressed as Mean ± SD for 10 rats in each group. Values were considered significantly different 
at P < 0.05. *: Significantly different when compared to control group I. β: significantly different when 
compared to HFD obese group. λ: significantly different when compared to HFD + Orlistat group  
 
 
Table 4: Levels of TBARS and activities of superoxide dismutase (SOD) and glutathione peroxidase 
(GPx) in the testis homogenates of all groups of rats 
 TBARS 
(mmol/mg) 
SOD 
(U/mg) 
GPx 
(mmol/min/ml) 
Control 1.34±0.042 10.28±1.45 51.89+4.67 
HFD 2.85±0.047* 5.35±1.05* 28.26±4.75* 
HFD + Orlistat 2.67±0.097* 5.67±1.45* 31.56±2.13* 
HFD + exercise 1.41±0.0231αβ 9.68±1.67 αβ 49.98±5.78 αβ 
Values are given as Mean ± SD and considered significant at P≤0.05.  
*: significantly different when compared to control group. α: significantly different when compared to HFD group. β: significantly 
different when compared to HFD + Orlistat treated group 
 
 
RT-PCR and Western blotting  
The levels of SCF and Ghrelin mRNAs 
expression were assessed in all experimental 
groups (Figure 6). On the basis of the cDNA 
sequence of SCF and selected primers, two 
fragment products were expected to be seen 
on the gel: 167 bp, representing the trans-
membrane form of SCE (SCFm), and 
250 bp, representing the soluble form of SCF 
(SCFs). In control non rats, both SCFs and 
SCFm transcripts were detected in the testes, 
and RT-PCR resulted in two DNA fragments 
similar in size to those expected (Figure 6B). 
As expected, SCFm had a higher level of ex-
pression. Also, Ghrelin mRNA was com-
pletely absent in the testes of control non rats 
as the resulted gel showed no visible band 
corresponding to Ghrelin in this group of rats 
(Figure 6A). On the other hand, HFD rats 
exhibited an opposite profile where Ghrelin 
mRNA exhibited a high level of expression 
(as shown by the clear band of 247 bp size), 
while both SCFs and SCFm mRNA were 
barely detectable in HFD group rats com-
pared to control non group rats (Figure 6). 
Interestingly, though, Ghrelin mRNA was 
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undetectable and both SCFs and SCFm 
mRNA became prominent in rats that un-
derwent exercise (i.e. Group 4). Additional-
ly, Orlistat had a similar effect to that of ex-
ercise on Ghrelin and SCF expression, how-
ever, to a much lesser extent since Ghrelin 
mRNA levels were still visible in the Orlistat 
receiving group. In regards to SCF mRNA in 
the Orlistat receiving group, SCFs was bare-
ly detectable while SCFm band was pro-
nounced (Figure 6B).  
Western blotting analysis of rat testes 
homogenate (Figure 7) revealed two bands 
with immunoreactivity for SCF, at 28-kDa 
and 19-kDa in all experimental groups, alt-
hough, with variable densities. Anti-Ghrelin 
antibody detected a single band of 50-kDa, 
while anti-β-actin antibody detected a single 
band of 48-kDa in all experimental groups. 
SCF immunoreactivity was quiet prominent 
in the control group (A1) rat testes homoge-
nate, decreased precipitously in HFD (A2) 
obese rats, was partially protected with 
Orlistat treatment (A3) and was essentially 
fully protected in rats underwent HFD and 
exercise (A4) protocol. Conversely, Ghrelin 
protein was barely detectable in the control 
group (B1) but had several folds increase in 
HFD group (B2) rats. Interestingly, Orlistat 
(B3) hardly inhibited Ghrelin in a manner 
comparable to its partial protection of SCF 
(A3) protein levels. Exercise profoundly pro-
tected SCF protein levels when compared to 
rats in groups 1 and 2. Exercise inhibited 
Ghrelin (B4) fully and completely protected 
SCF protein levels (A4). Figure 7C is a con-
trol for equal protein loading in all lanes. 
 
 
Figure 6: RT-PCR detection of Ghrelin (A) (247 bp,) and soluble (SCFs, 250 bp) and transmembrane 
(SCFm, 167 bp) forms of SCF (B) mRNAs in whole testis. The RT-PCR product, obtained from all 
groups was separated by 2 % agarose gel electrophoresis. N: negative control. L: 50 bp ladder. C: 
Control non obese rats. H: high fat diet (HFD) obese group. HO: HFD + Orlistat group. HE: HFD + ex-
ercise group 
 
 
 
Figure 7: Western analysis of stem cell factor (SCF, A), Ghrelin (B) and β actin (C) proteins in the tes-
tis homogenates of all groups. SCF protein detection can be seen at 2 bands of 28-KDa and 19-KDa 
whereas Ghrelin and β-actin were detected at 48-KDa and 50-KDa band, respectively. 1: Control non 
obese rats. 2: high fat diet (HFD) obese group. 3: HFD + Orlistat group. 4: HFD+ exercise group  
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DISCUSSION 
In this study, the validity and reliability 
of a rat model for High Fat Diet induced-
obesity were first established in our lab. The 
evidence includes the significant waist obesi-
ty, the massive weight increase, appreciably 
elevated adipose tissue deposition, signifi-
cantly reduced sperm count, sperm motility, 
and daily sperm production, hyperlipidemia, 
the reduced levels of testosterone, FSH, LH, 
and the elevated leptin. The model was uti-
lized to test the hypothesis that obesity in-
duces Ghrelin expression, which in turn 
downregulates SCF and results in semen ab-
normalities; an effect that can be protected 
against non-pharmacologically via using en-
durance exercise, or pharmacologically, us-
ing lipase inhibitor Orlistat. Our data clearly 
demonstrated that diet induced-obesity in-
creased Ghrelin mRNA and protein, and re-
duced or abolished SCF mRNA and protein 
in the testes. It further showed a significant 
reduction in sperm count, sperm motility, 
sperm morphology and DSP as well as in-
creased levels of TBARS and reduced activi-
ties of SOD and GPx. Complete or partial 
protection against these effects was enabled 
by exercise and Orlistat, respectively. 
In the testes of obese rats, there exists a 
direct and inverse relationship between 
Ghrelin and SCF both at the level of mRNA 
and protein. This finding is significant since 
it sheds some light on the mechanism relat-
ing obesity to infertility. Though the current 
study is observational in nature, it brings to 
light a new molecule in the phenomenon of 
obesity-associated-infertility and semen ab-
normalities, namely, SCF in the testes. Our 
data argues that obesity in males negatively 
impacts fertility by downregulating Hypotha-
lamic-Pituitary Gonadal (HPG) axis which 
results in increased Ghrelin gene expression 
that inhibits SCF gene expression. The inhi-
bition of SCF gene expression induces ab-
normalities in already formed sperms in ad-
dition to inhibiting the formation of new 
sperms (Figure 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Tentative mechanistic model linking 
fertility to obesity 
 
 
Experimentally in our study, an obesity 
model induced by high-fat diet consumption 
was chosen since it effectively and reproduc-
ibly produced obesity in dogs, pigs, ham-
sters, squirrels, mice (West and York, 1998), 
and rats (Tuzcu et al., 2011). The high-fat 
diet used in the present study was effective 
in producing obesity over a period of 12 
weeks, as demonstrated by increased serum 
levels of leptin, TG, TC, LDL, adiposity in-
dex, body weight accompanied with a signif-
icant decrease in HDL and Ghrelin levels. 
These findings are in agreement with various 
reports (Tuzcu et al., 2011; West and York, 
1998; Tan et al., 2005; Archer and Mercer, 
2007). However, few studies in the literature 
examined changes in individual organ 
weight in obese individuals. Here we report a 
direct effect of the HFD consumption on the 
individual weight of testis and epididymis 
HFD-Induced Obesity 
In the Blood:  
↓FSH ↓ LH ↑Leptin 
↓ HDL ↑ LDL ↑ TC  
↓ Testosterone  ↑Triglycerides 
In the Testes: 
↑ Ghrelin mRNA  ↑Ghrelin protein 
↓ SCF mRNA  ↓ SCF protein 
↓ SOD activity ↓ GRx activity  ↑ TBARS 
Pathophysiological manifestation in the testes:
 
↑ Fat deposit on the Testes  
↑ Fat deposit on Epididymis 
↓ LH pulse frequency  
↓ Spermatogenesis 
↓ Sperm count  
↑ Sperm morphological deformities 
     Impairs Leydig cells development 
     Impairs Leydig cells induced differentiation 
     Dysregulate seminiferous epithelium 
     Delayed puberty 
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relative to total body weight. Though varia-
tions on this issue have been published (Ed-
monds et al., 1982; Ghanayem et al, 2010), 
those variations can be attributed to animal 
model genetics as well as protocol differ-
ences. The significant decrease in the abso-
lute and relative weights of testis and epidi-
dymis in obese rats suggests that sperm mor-
phology and production (i.e. spermatogene-
sis) could also have been impaired. There-
fore, a detailed sperm analysis was conduct-
ed to detect, if present, abnormalities that 
could shed some light on obesity-associated 
male infertility. Interestingly, when com-
pared to control rats, obese rats exhibited 
lower daily sperm production (DSP), sperm 
concentration, sperm motility in addition to 
abnormal sperm morphology. Our findings 
are in agreement with Jensen et al. (2004) 
who reported higher prevalence of oligozoo-
spermia in overweight and obese men than in 
normal weight men, with a significant asso-
ciation between sperm count and BMI. Also, 
Koloszar et al. (2002) reported decreased 
sperm count in obese normozoospermic men 
compared with non obese fertile subjects. 
Kort et al. (2006) reported a negative corre-
lation between BMI and total number of 
normal spermatozoa, and Sallmen et al. 
(2006) showed that overweight and obese 
men had reduced sperm motility and in-
creased sperm DNA fragmentation. Also, 
Sprague-Dawley rats fed a high fat diet from 
21 to 90 days are presented with a reduced 
sperm concentration (Vigueras-Villaseñor et 
al., 2011).  
Oxidative stress may be a key mecha-
nism linking overweight or obesity with 
male infertility and inducing increased sperm 
DNA damage. The testicular microenviron-
ment has been reported to be exposed to oxi-
dative stress and a positive correlation be-
tween BMI and seminal oxidative stress has 
been observed in both animals (Bakos et al., 
2011) and human (Tunc et al., 2011). Al-
though reactive oxygen species (ROS) are 
essential for normal reproductive functions, 
namely, sperm capacitation and acrosome 
reaction, when present at physiological con-
centrations. However, they become toxic and 
damaging at higher concentration (Al-
lamaneni et al., 2004, Aitken et al., 2004). 
Spermatids and mature spermatozoa are 
quite sensitive to ROS because their mem-
branes are rich in polyunsaturated fats (Al-
lamaneni et al., 2004) which undergo lipid 
peroxidation and generate damaging reactive 
carbonyl compounds such as MDA (Al-
lamaneni et al., 2004, Aitken et al., 2004). 
Hence, sperms may be impaired, and/or die 
depending on how much ROS levels have 
increased under oxidative stress conditions 
(Agarwal et al., 1994). Our data is in agree-
ment with Bakos et al. (2011) where signifi-
cant increase in the levels of testicular lipid 
peroxides was observed, since we detected 
an increase in TBARS levels as well as a 
significant reduction in SOD and GPx activi-
ties in the testes of the rats fed with HFD. 
The results confirmed that obesity did en-
hance testicular oxidative stress. The present 
experimental design does not elucidate the 
obesity-infertility signal transduction path-
way, nevertheless, our results argue that it 
includes key downstream effectors in the tes-
tes, namely, Ghrelin, SCF, SOD, GPx, and 
TBARS which cause semen abnormalities 
and could ultimately precipitate male infertil-
ity.  
A disturbance in sex hormones, namely 
GnRH, FSH, LH, testosterone and estrogen 
of the HPG axis, is primarily suspected to 
trigger the above observed abnormalities in 
sex organs weight, sperm morphology and 
spermatogenesis (Mah and Wittert, 2010). 
This hypothesis is based on the hormonal 
abnormalities observed in individuals with 
increased BMI where decreased levels of 
testosterone and increased levels of estrogen 
were observed in obese rats (Chavarro et al., 
2010). This imbalance resulted in decreased 
testosterone to estrogen ratio, which was 
shown to be caused in obese individuals by 
increased activity of the cytochrome p450 
aromatase enzyme; the enzyme that converts 
androgens to estrogens (Phillips and 
Tanphaichitr, 2010). The levels of testos-
terone, FSH and LH, reported here were all 
decreased in the HFD fed rats. Collectively, 
data suggests that the diet-induced obesity in 
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rats could trigger an upstream signalling 
pathway starting with downregulation of tes-
tosterone, FSH and LH leading to down-
stream and localized upregulation of Ghrelin 
in the testes, that in turn downregulates SCF, 
gene expression and reduces SOD and GPx 
enzymatic activities thus casing sperm de-
formities and sperm death. 
Ghrelin was reported to be expressed in 
Leydig cells and to a lesser extent in Sertoli 
cells of normal rat testis (Gaytan et al., 
2004). This observation suggested an im-
portant role in the regulation of reproduction 
and fertility. Functionally, Ghrelin has been 
shown to have multiple roles in the testes 
including inhibition of proliferative activity 
of immature Leydig cells in vivo, delay of 
pubertal onset in male and inhibition of tes-
tosterone secretion in stimulated rat testis 
(Tena-Sempere et al., 2002; Barreiro et al., 
2004). 
Incidentally, Stem Cell Factor was also 
found expressed by Leydig cells and sper-
matogonia (Loveland and Schlatt, 1997), 
where it binds to the c-kit receptor found 
immunolocalized to acrosomal granules of 
spermatocytes and the acrosomes of sperma-
tozoa (Sandlow et al., 1999). Deletion or mu-
tations of the c-kit gene or its ligand, SCF, 
have been reported to result in infertility in 
mice due to loss of germ cells (Besmer et al., 
1993). In congruence with these observa-
tions, here we report a decreased expression 
of SCF (both soluble and transmembranous) 
in the testis of obese rats.  
Ghrelin has been shown to control the 
secretion of SCF (Barreiro et al., 2004) as 
evident by inhibition of SCF gene expression 
consequent to intratesticular injection of 
Ghrelin (15 μg for two days) in adult rats in 
vivo (Barreiro et al., 2004) and in vitro using 
cultures of staged seminiferous tubules. This 
suggests that Ghrelin is acting upstream of 
SCF in the testes of obese rats. A higher up 
step in the regulation of SCF is FSH, which 
has been shown to directly stimulate SCF 
synthesis (Yan et al., 1999). Therefore, it is 
plausible to postulate that the observed de-
cline in FSH in obese rats precipitated a de-
cline in SCF, as well as the observed sperm 
deformities and sperm count. 
It is noteworthy that FSH and SCF can 
protect germ cells from apoptosis by inhibit-
ing the expression of key apoptotic genes 
such as Bok (Yan et al., 1999, 2000), a pro-
apoptotic member of the Bcl-2 gene family. 
In this study, we did not assess Bok expres-
sion, but Bok mRNA was detected in sper-
matogonia, pachytene spermatocytes and 
Sertoli cells in rat testis in a previous study 
(Suominen et al., 2001). Put together, we are 
proposing the following hypothesis: obesity 
associated infertility and sexual dysfunction 
are controlled centrally via FSH which in 
turn regulates the interplay between testicu-
lar SCF and Ghrelin expression, which in 
turn keeps key apoptotic genes suppressed. 
Therefore, it is likely that the HFD induced-
obesity impaired the semen parameters and 
decreased semen count and motility by de-
creasing circulatory FSH, which inhibited 
SCF signalling thus increasing Ghrelin ex-
pression in rats’ testes, a mechanism that 
could be stimulating Bok gene expression 
and triggering sperm apoptosis. The inter-
play between the trio, downregulation of 
SCF, reduced activities of SOD and GPx, 
and upregulation of Bok gene expression, 
leading to sperm deformation, sperm death, 
and ultimately infertility and sexual dysfunc-
tion, should be the focus of future research.  
Rather than pursuing the molecular regu-
lation of Ghrelin, SCF, and apoptosis in the 
testes, we chose to fast forward to testing if 
exercise and lipase inhibition individually 
could reverse the effect of obesity on semen 
abnormalities.  
Orlistat (Xenical), an inhibitor of gastric 
and pancreatic lipase lowering fat absorption 
by 30 %, has been proven to be useful in fa-
cilitating both weight loss and weight 
maintenance (Gürsoy et al., 2007). The data 
presented here showed that co-administration 
of Orlistat with the HFD, had multiple bene-
ficial effects including partial protection 
against obesity associated-loss of absolute 
and relative weights of testes and epididy-
mis, a significant reduction in visceral, retro-
peritoneal, and epididymal fat deposit, near 
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complete normalization of lipid profile, re-
sisting the decline in FSH, LH, testosterone 
and estradiol, as well as reduction of leptin 
and Ghrelin in the HFD fed rats. Also, it par-
tially ameliorated oxidative stress in rats’ 
testes by decreasing lipid peroxidation levels 
and restoring SOD and GPx activities. How-
ever, it did not protect against obesity asso-
ciated sperm deformities nor did it reverse 
Ghrelin and SCF gene expression.  
In regards to exercise, its benefits have 
been attributed, at least in part, to counteract-
ing the biological adaptation that drive 
weight gain and regain (Levin and Dunn-
Meynell, 2004). In the periphery, exercise 
promotes fat oxidation and prevents relapse-
induced hypercellularity in abdominal fat 
pads (Levin and Dunn-Meynell, 2004). As 
shown earlier, the effects of exercise on 
obese rats were unparalleled. Not only, it 
produced all of the effects of Orlistat de-
scribed above, but changes were even more 
pronounced. Apart from Orlistat, exercise 
significantly normalized sperm deformities 
seen in obese rats. Furthermore, closer com-
parison of the effects of exercise and Orlistat 
revealed that while Orlistat has a partial pro-
tective action, exercise led to full protection 
against changes in the levels of sex hor-
mones, lipid profile, semen parameters via 
abolishing testicular Ghrelin levels, increas-
ing testicular SCF levels and correcting 
sperm deformities in the testis.  
Concerning antioxidant effects of exer-
cise, a significant body of literature proved 
that acute exercise causes oxidative and mi-
tochondrial stress and tissue injury (Leeu-
wenburgh and Ji, 1995; Liu et al., 2000; 
Huang et al., 2008). However, a substantial 
body of evidence suggests that regular exer-
cise plays an important preventive and thera-
peutic role in oxidative stress-associated dis-
eases, including ischemic heart disease, heart 
failure, type II diabetes, and Alzheimer’s 
disease (Kiraly and Kiraly, 2005; Lazarevic 
et al., 2006; Ascensão et al., 2006; Belar-
dinelli et al., 2007). In animals and humans, 
studies have shown that exercise clearly 
permits significant adaptive responses such 
as greatly increased endurance capacity. The 
increased capacity is permitted by the dra-
matic mitochondrial biogenesis, the reduc-
tion in oxidant’s production and increased 
antioxidant defences (Packer and Cadenas, 
2007; Sachdev and Davies, 2008). In 2011, 
Botezelli et al. demonstrated that eight 
weeks of swim training decreased lipid per-
oxidation, a fact partially attributed to an im-
proved antioxidant system with greater SOD 
enzyme activity. Accordingly, it has been 
demonstrated that endurance training up-
regulates antioxidant enzymes and glutathi-
one content improves mitochondrial respira-
tory function and reduces lipid peroxidation 
by products in various tissues (Vendittim and 
Di Meo, 1996; Powers et al., 1998; Ramires 
and Ji, 2001). These findings are in agree-
ment with our results where SOD and GPx 
activities were elevated in rat testes in Group 
4 (HFD + exercise) rats. Together, besides 
its ameliorating effect on the Ghrelin and 
SCF gene expression in obese rats’ testes, 
endurance swimming exercise also provides 
protection to semen parameters by boosting 
antioxidant potential in the testes.    
In conclusion, the significant effects of 
exercise and Orlistat observed here present a 
strategic intervention to protect against obe-
sity induced semen abnormalities. While 
Orlistat seems to act through decreasing 
body weight, decreasing circulatory lipids 
and enhancing hormonal imbalance, endur-
ance swimming exercise on the other hand, 
seems to act through other mechanisms in-
cluding mitigation of oxidative stress, boost-
ing hormonal imbalance and reversing the 
levels of Ghrelin and SCF in the testes of 
obese rats.  
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